NASDAQ: AKTX - Akari Therapeutics, Plc

Lønnsomhet i seks måneder: -67.47%
Utbytte: 0.00%
Sektor: Healthcare

Kampanjeplan Akari Therapeutics, Plc

Avansert tidsplan Enkel graf
Financial Markets by TradingView

Om selskapet Akari Therapeutics, Plc

Akari Therapeutics, Plc, a clinical-stage biopharmaceutical company, focuses on developing advanced therapies for autoimmune and inflammatory diseases.

flere detaljer
Its lead product candidate is nomacopan, a second-generation complement inhibitor that prevents inflammatory and prothrombotic activities, including paroxysmal nocturnal hemoglobinuria, Guillain-Barré syndrome, hematopoietic stem cell transplant-associated thrombotic microangiopathy, and bullous pemphigoid, as well as pre-clinical program developing long-acting PASylated-nomacopan for treatment of geographic atrophy secondary to dry age-related macular degeneration. The company is based in London, the United Kingdom.
Legg til i sammenligningslisten
Legg til overvåkningsliste
Legg til portefølje
Legg til prisvarsel

IPO date 2015-09-21
ISIN US00972G1085
Industry Pharmaceuticals
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.akaritx.com
Цена ао 0.9079
Prisendring per dag: 0% (1.08)
Prisendring per uke: +20% (0.9)
Prisendring per måned: -0.6257% (1.0868)
Prisendring over 3 måneder: +9.31% (0.988)
Prisendring over seks måneder: -67.47% (3.32)
Prisendring per år: -46% (1.9999)
Prisendring over 3 år: -7.3% (1.165)
Prisendring over 5 år: -45.18% (1.97)
Prisendring siden begynnelsen av året: +11.34% (0.97)
Alle parametere

Undervurdering

Navn Betydning Karakter
P/S 0 0
P/BV -65.19 0
P/E 0 0
EV/EBITDA -0.6596 0
Total: 2.5

Effektivitet

Navn Betydning Karakter
ROA, % -229.8 0
ROE, % 4370.31 10
Total: 3.33

Utbytte

Navn Betydning Karakter
Div yield, % 0 0
DSI 0 0
Total: 0

Plikt

Navn Betydning Karakter
Debt/EBITDA 0 10
Total: 10

Vekstimpuls

Navn Betydning Karakter
Lønnsomhet Revenue, % 0 0
Lønnsomhet Ebitda, % -32.79 0
Lønnsomhet EPS, % 110.99 10
Total: 3
Flere detaljer

Institusjoner Volum Dele, %
Sabby Management, LLC 164026 2.07
Omnia Family Wealth, LLC 87628 1.11
Cerity Partners LLC 23643 0.3
Renaissance Technologies, LLC 10269 0.13
Bank of America Corporation 150 0
Truvestments Capital, LLC 50 0
Morgan Stanley 8 0
Tower Research Capital LLC (TRC) 7 0
Cornerstone Planning Group LLC 5 0



Veileder Stillingstittel Betaling Fødselsår
Ms. Wendy F. DiCicco CPA Interim Chief Financial Officer 540.34k 1967 (58 år)
Dr. Miles Nunn Chief Scientific Officer N/A 1969 (56 år)
Dr. Samir Rashmikant Patel M.D. Interim President, CEO & Director 3.7k 1969 (56 år)

Adresse: United Kingdom, London WG RT, 75/76 Wimpole Street - åpne i Google maps, åpne Yandex-kart
Nettsted: https://www.akaritx.com